That was just a rebound back to normal for her company's stock. It tanked during the whole trial/imclone debacle, but it is back where its worth. Whatever one may think of her, her company has good business fundamentals and good products, so to see it rebound would be expected...
Well, not really.
The magazine is losing money and so is the company as a whole.
After the peak of the "America will love Martha after she pays her dues" hype, the stock is again heading South.